• Increase font size
  • Default font size
  • Decrease font size

NovaBay set for “phenomenal year” with key announcements and partnership developments

Print E-mail
Written by Staff and Wire Reports   
Tuesday, 20 March 2012 03:46
NovaBayIf you haven't become familiar with NovaBay Pharmaceuticals (AMEX:NBY), now may be a good time to start. The Emeryville, California based firm has announced several key developments and catalysts which could affect price action.
Read more...
 

Cardiome Provides Update on Merck's Development Plans; Watson Confirms Patent Challenge

Print E-mail
Written by Staff and Wire Reports   
Monday, 19 March 2012 19:12
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 19, 2012.
Read more...
 

Why Ampio's Rebound Run May Not Be Done

Print E-mail
Written by M.E.Garza   
Monday, 19 March 2012 14:10
Shares of Ampio Pharmaceuticals (NASDAQ:AMPE) rocketed over 60% to a high of $4.58 on Monday after the company decided to end a study for its ophthalmology drug Optina™ ahead of schedule due to positive preliminary results and there are plenty of hints that the bulls may not be done here.
Read more...
 

Report: Anti-smoking legislation could generate $700 million a year for cancer research

Print E-mail
Written by Staff and Wire Reports   
Monday, 19 March 2012 10:47
{nfg}Expert BriefingWith California voters set to vote in June on a proposition (Prop 29) that would generate more than $700 million a year for cancer research and anti-smoking efforts through a new $1 a pack tax on cigarettes,
Read more...
 

Positron's Acquisition of Manhattan Isotope is a game changer

Print E-mail
Written by Beth McElhenny & Philip Tate   
Friday, 16 March 2012 00:00

Positron (OTC:POSC.OB) shares still look undervalued following news of the acquisition of Manhattan Isotopes Technologies (MIT). MIT is a game changer for the company. 

Read more...
 

Mylan Drops Out of Rottapharm Talks; Shire Pulls FDA Application for Second Time

Print E-mail
Written by Staff and Wire Reports   
Thursday, 15 March 2012 19:22
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 15, 2012.
Read more...
 

FDA Approves First Generic To Treat Depression; Endocyte to Submit EU Conditional Marketing Authorization Applications

Print E-mail
Written by Staff and Wire Reports   
Wednesday, 14 March 2012 20:07
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 14, 2012.
Read more...
 

Know Your Medtech Growth Drivers

Print E-mail
Written by By George S. Mack of The Life Sciences Report   
Wednesday, 14 March 2012 00:00
Medical technology has been stalled in a quagmire of regulation, lowered usage and a more tight-fisted health insurance environment, but Analyst and Managing Director Joanne Wuensch of BMO Capital Markets has identified a few ground-breaking technologies that will drive increasing cash flows in particular companies.
Read more...
 

Omeros' OMS302 Achieves Primary and Secondary Endpoints; Cornerstone Receives FDA Acceptance

Print E-mail
Written by Staff and Wire Reports   
Tuesday, 13 March 2012 20:04
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 13, 2012.
Read more...
 

Upcoming FDA decision has speculators betting on Affymax

Print E-mail
Written by Brian Wilson   
Tuesday, 13 March 2012 00:00
Affymax (NASDAQ:AFFY) is a pharmaceutical company worth $393 million that is in the process of developing the drug Peginesatide, which is an investigational drug that treats anemia associated with chronic kidney disease (CKD).
Read more...
 
<< Start < 1 2 3 4 5 6 7 8 10 > End >>

Page 10 of 237
about 5 minutes ago $AMLN Said to Attract Interest From Pfizer, AstraZeneca - Businessweek http://t.co/PFKT6LE8
about 46 minutes ago Stock Market: Stocks Extend Losing Streak http://t.co/ZmZxvJiO
about 2 hours ago Cancer Survivors Who Exercise Live Longer http://t.co/U4MhX04a
about 3 hours ago Colon cancer screenings that don’t require laxatives are almost as effective as colonoscopies and may encourage more tests http://j.m
about 4 hours ago Testing a Drug That May Stop Alzheimer’s Before It Starts $RHHBY http://t.co/Wjgw15IS
about 4 hours ago Two patients get eye stem cells transplanted to restore sight http://t.co/HHYZlFFT
about 4 hours ago US Senate call to scrap drug patents: http://t.co/W1BOuxJp
about 4 hours ago http://t.co/MAgh4Xke

navigation

Free Phone Trade Alerts

Benzinga.com supporter Seeking Alpha Certified